Search results
Aldosterone Synthase Inhibitors
Author(s):
Shubh K Patel
,
Hwee Teoh
,
Ahreni Saunthar
,
et al
Added:
9 months ago
Review Article
Aldosterone and Potassium in Heart Failure
Author(s):
Laibah Arshad Khan
,
Adeena Jamil
,
Stephen J Greene
,
et al
Added:
1 year ago
Review Article
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s):
Rishi Sethi
,
Pravesh Vishwakarma
,
Akshyaya Pradhan
Added:
1 year ago
Review Article
ARNI for Optimising HFrEF Management
Author(s):
Massimo Iacoviello
,
Filippo M Sarullo
,
Claudio Bilato
,
et al
Added:
10 months ago
Expert Opinion
Author(s):
Vijay Chopra
Added:
1 year ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps…
View more
Thomas Kahan
Author
Author(s):
Thomas Modine
Added:
1 year ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Conduction System Pacing: A Fresh Look
Author(s):
Óscar Cano, Marek Jastrzębski, Pugazhendhi Vijayaraman
Start date:
Nov 13, 2024
Broadcast
Author(s):
David Zizek
Added:
3 weeks ago
HFA Congress 2026 — Dr David Žižek (University Medical Centre Ljubljana, Ljubljana, SI) joins us to discuss findings from CONDUCT-AF, a randomised, multicentre trial comparing conduction system pacing (CSP) with biventricular (BiV) pacing following atrioventricular node ablation (AVNA) in heart failure patients with symptomatic atrial fibrillation and narrow QRS.The trial enrolled 82 patients…
View more
